AIM
PAHC icon

Aigen Investment Management’s Phibro Animal Health PAHC Stock Holding History

Aigen Investment Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,318
Closed -$296K – 884
2025
Q3 		$296K Buy
+7,318
New +$242K 0.05% 541
2020
Q3 		– Sell
-18,381
Closed -$483K – 1052
2020
Q2 		$483K Buy
18,381
+871
+5% +$21.6K 0.06% 471
2020
Q1 		$423K Buy
17,510
+9,317
+114% +$228K 0.06% 485
2019
Q4 		$203K Buy
+8,193
New +$190K 0.03% 547

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aigen Investment Management's PAHC Position: Q4 2025 in Review

Aigen Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 7,318 shares — an estimated $296K sold.

Aigen Investment Management first reported a position in PAHC in Q4 2019 and held it in 4 quarters. The position peaked at $483K in Q2 2020. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • Aigen Investment Management reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 7,318 Phibro Animal Health shares in Q4 2025, an estimated $296K.
  • Aigen Investment Management first reported a position in Phibro Animal Health in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Phibro Animal Health position peaked at $483K in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.